Cardiology Haematology Strong — Fang 2011 / ATRIA Study
ATRIA Bleeding Risk Score
Predicts major bleeding risk in patients with atrial fibrillation on warfarin anticoagulation. Complements HAS-BLED.
References
- Fang MC et al. A new risk scheme to predict warfarin-associated hemorrhage: the ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study. J Am Coll Cardiol. 2011.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Warfarin Dose Adjustment Calculator · Anticoagulation
- DOAC Score for Selecting Direct Oral Anticoagulant in Non-Valvular AF · Anticoagulation
- ORBIT Bleeding Risk Score for Anticoagulation in AF Patients · Anticoagulation
- Heparin Infusion Dose Calculator · Anticoagulation
- Paediatric INR Goals for Mechanical Heart Valves · Anticoagulation
Drugs
- Warfarin · Anticoagulant
- Bivalirudin (PCI Anticoagulation) · Direct Thrombin Inhibitor / PCI
- Vernakalant · Atrial-selective antiarrhythmic
- Prothrombin Complex Concentrate (PCC) · Coagulation Factor Concentrate — Warfarin Reversal
- Vasopressin / Terlipressin · Vasopressin Analogue — Vasodilatory Shock / Variceal Bleeding
- Bivalirudin · Anticoagulation
Pathways
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.